Skip breadcrumb navigation Skip Navigation Links Home > Advocacy > Letters to Congress & Regulatory Agencies

SHM Letters to Congress and Regulatory Agencies

Part of the Society of Hospital Medicine's (SHM's) advocacy efforts is supporting legislation that affects hospital medicine and general healthcare. Here you can find any letter supported and signed by SHM to Congressional leaders and regulatory agencies.

Do you have comments related to the topics of SHM's letters to Congress? Visit SHM's online Advocacy and Public Policy community forum to share your thoughts and reactions and get feedback from colleagues.

Letters from 2017

SHM Sends Letter on Reducing Regulatory Burdens in Current Pay-for-Performance Programs
SHM sends letter to CMS Administrator Verma and HHS Secretary Price on reducing the regulatory burden in PQRS, VM, and MU programs. (May)

SHM Submits Comments on Episode-Based Measures in MACRA
SHM submitted comments to Medicare via the development of episode-based cost measures in MIPS. (April)

SHM Signs onto AHRQ Multi-Stakeholder Letter to House and Senate
Along with other organizations, SHM submits letter asking that AHRQ funding be protected. (April)

SHM Comments on Implementation of Advanced BPCI
SHM submitted recommendations and comments to CMS on their Advanced Bundled Payment for Care Improvement (BPCI) Initiative.

SHM Sends Letter of Support for the Nomination of Scott Gottlieb, MD to FDA
SHM sends a letter to the Senate Health, Education, Labor and Pensions Committee in support of Scott Gottlieb, MD as Commissioner of FDA. (March)

Past Letters